NORDIC BIOSCIENCE HOLDING A/S: Financial statements 2020
CVR: 30511271
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NORDIC BIOSCIENCE HOLDING A/S (CVR 30511271) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 79,886,444 compared with DKK 109,911,965 the year before. Equity in the 2020 report amounted to DKK 136,415,962. The solvency ratio was 37.6%. The company had 219 employees in the financial year.
- Profit/Loss
- DKK 79,886,444
- Equity
- DKK 136,415,962
- Total Assets
- DKK 363,236,532
- Employees
- 219
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 79.9 mio. | 136.4 mio. | 219 |
| 2019 | - | - | 109.9 mio. | 282.4 mio. | 2 |
| 2018 | - | - | 38.3 mio. | 237.8 mio. | 2 |
| 2017 | - | - | 289.7 mio. | 597.5 mio. | 2 |
| 2016 | - | - | 3.2 mio. | 316.7 mio. | 133 |
Official annual report
How creditworthy is NORDIC BIOSCIENCE HOLDING A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NORDIC BIOSCIENCE HOLDING A/S has published its annual report for 2019. The net result was DKK 109,911,965.
About NORDIC BIOSCIENCE HOLDING A/S
NORDIC BIOSCIENCE HOLDING A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Asser Karsdal. The board consists of Claus Henrik Christiansen (chair), Steffen Kragh, Henrik Bernt Sanders and Kugan Sathiyanandarajah. The company is owned by Nordic Life Science Consulting ApS, Romarine ApS and KKR Precision Aggregator L.P.. The company has 1 employee (2025). In 2025, the company reported revenue of DKK 426,285,000 and a net result of DKK 54,532,000 compared with DKK 170,813,000 the year before. Equity in the 2025 report amounted to DKK 71,184,000.
